Tactile Systems Technology, Inc. TCMD

Moby summary of Tactile Systems Technology, Inc.'s Q2 2026 earnings call

MINNEAPOLIS, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results for the second quarter ended June 30, 2026. Second Quarter 2026 Summary and Recent Business Highlights: Total revenue increased 9% year-over-year to $85.7 millionGross margin expanded to 76% from 75% in Q2 2025Net income increased to $7.8 million from

Inogen (INGN) delivered earnings and revenue surprises of +17.65% and +0.30%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

MINNEAPOLIS, July 21, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that second quarter of fiscal year 2026 financial results will be released after the market closes on Monday, August 10, 2026. Management will host a conference call with a question and answer session at 5:00 p.m. Eastern Time on August 10, 2026, to discuss the results

Discreet, Battery-Powered Device Reaches Patients at Earlier Stages of Disease ProgressionMINNEAPOLIS, July 13, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced it has entered into an exclusive distribution agreement with ElastiMed, Inc. to bring MyoSleeve™, its discreet, wearable non-pneumatic compression device for the lower leg, to Dep

Reduced Weight, Expanded Size Adjustability, and Built-in Wi-Fi & Bluetooth® Deliver a More Comfortable, Connected Patient Experience Without Compromising Clinical EffectivenessMINNEAPOLIS, June 02, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced full commercial launch of its next-generation AffloVest high-frequency chest wall oscillatio

MINNEAPOLIS, May 20, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that management will participate in the William Blair 46th Annual Growth Stock Conference, which is being held at the Loews Hotel in Chicago, IL, from June 2-4, 2026. Management will present on Tuesday, June 2, at 9:20 a.m. Central Time. A live audio webcast of the pres

Tactile Systems Technology, Inc. ( NASDAQ:TCMD ) defied analyst predictions to release its first-quarter results, which...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Moby summary of Tactile Systems Technology, Inc.'s Q1 2026 earnings call

Tactile Systems Technology (NASDAQ:TCMD) reported first-quarter 2026 revenue of $75.3 million, up 23% year-over-year, as management pointed to “focused execution” on strategic priorities, continued commercial momentum, and operational changes made ahead of Medicare’s new prior authorization requirem

Tactile Systems Technology (TCMD) delivered earnings and revenue surprises of -9.14% and +5.88%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?